The Prime Therapeutics Report is your trusted source for the latest in managed care strategies, specialty drug trends and payer-focused insights. The Summer 2025 issue features a cover story on HIV...

Hemophilia Federation of America HemophiliaFed.org Hemophilia Schedule now Your browser does not support inline frames or is currently configured not to display inline frames. Content can be viewed...

Cognos accessibility information Accessibility standards Prime Therapeutics is committed to providing accessible reporting experiences. Cognos Analytics includes features that support...

Example Link Example Link Staying productive Helpful office setup tips paired with high-performing technology help employees stay productive at home. Relationships thrive at our hub Through our Hub...

As prescription opioid overdoses rise in the U.S., the Prime/MRx Special Investigations Unit (SIU) shares how to identify if someone has overdosed and how you can help save a life

Education reimbursement and professional development Generous paid time off, including nine holidays Adoption reimbursement up to $5,000 An employee assistance program (EAP) Discounts Four weeks of...

At Prime Therapeutics (Prime), we’re a different kind of pharmacy benefit manager (PBM). We’re reimagining pharmacy solutions to provide the care we would want for our loved ones. That purpose...

Jessica Johnson, clinical consultant, shares how to identify and prevent opioid overdoses

New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more

Year 2 Prime Therapeutics’ leading research shows 1 in 12 remain on a GLP-1 drug for obesity at three years. Findings also show improved persistence with high-potency, obesity-approved GLP-1...

Tap into our Expert Clinical Network Prime received a request for a nonformulary biologic in a young patient with severe Crohn’s disease, as the provider documented past failures of a biologic on...

Footnotes When we say we are different from our competition, we truly mean it. At Prime, we are driven by our purpose of providing the care we would want for our loved ones. Explore how we stay...

Ashley Block Week of Service is an annual event that allows our employees to come together to support our five charity partners, many of which address the major health care conditions we help our...

From cutting-edge system solutions to powerful stakeholder partnerships, the Medicaid Enterprise Systems Conference delivered key insights and connections that will shape health care modernization...

In this episode of "Beyond the Script," join Jami Snyder, Ann Walker and Tina Hawkins, PharmD to learn more about the need for states to closely manage physician administered drugs (PADs) and how...

Real-world, integrated data follows-up on previous insights, analytics.

Whitepaper Tab 1 Myth 1 Myth 2 Myth 3 Myth 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed nec ornare mi. Praesent ultrices ipsum eget est rutrum, eget congue orci molestie. Sed diam...

Evaluating Case Management Referral Patterns: Insights From an Enhanced Utilization anagement Program Real-World Patterns of On-Demand Therapy Utilization Following Initiation of Long-Term...

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in Las Vegas.

Senior Account Manager - Remote Investment Accountant, Principal - Remote Job description: The Senior Financial Application Analyst is responsible for the administration of the Hyperion application...

Please enter a valid video URL. The URL can point to any video file or a Youtube video. Please enter a valid video URL. The URL can point to any video file or a Youtube video. Reimagine a PBM with...

April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth leading cause of cancer related death.¹ In 2023, approximately 64,050 people were...

References Sadelain M. Engineering the future – innovation in CAR T therapy design. Presented at Precision Medicine World Conference. March 4, 2026: Santa Clara, CA. Harris E, June C, Sadelain M....

Clinical Solutions Vice President (Remote) Job description: The Medicare Part D pharmacy programs manager manages the coordination of benefits in the pharmacy program with Medicare Part D plans,...

Prime Therapeutics’ newest Clinical Insights explores emerging evidence and innovations influencing treatment strategies and shaping healthcare decision-making

High Cost Therapy Profile Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) Gene Therapy/Immunology Marnetegragene autotemcel...

NCCN Recommendations for use of immunoglobulin² Intervention CAR T BsAbs Other indications Immunoglobulin replacement After CAR T-cell therapy, regular immune globulin infusions based on clinical...

Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

FDA approved BiTEs: Brand name Generic name Route Target Indication First FDA indication approval date Blincyto Blinatumomab IV anti-CD19 / anti-CD3 Acute lymphocytic leukemia 12/3/2014 Columvi...

Clinical Solutions VP (Remote) Looking for your next career move and want to help Prime Therapeutics (Prime) put more care in health care? Check out the Prime Careers Spotlight, a monthly roundup...

Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...

Tab 1 BEHAVIORAL HEALTH CORNER WEIGHT MANAGEMENT CORNER Clinical News EDITOR-IN-CHIEF: Maryam Tabatabai, PharmD EXECUTIVE EDITOR: Anna Schreck Bird, PharmD DEPUTY EDITORS: Erik Hamel, PharmD;...

Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC Drug name/Manufacturer/Dosage form semaglutide (Wegovy)/Novo Nordisk/SC tirzepatide (Zepbound)/Eli Lilly/SC T2DM Access the complete...

Greg Myers, vice president of AI strategy at Prime Therapeutics, shares how AI is creating value for healthcare payers — and what it takes to scale it responsibly

The CDC is reporting influenza-like illness (ILI) for the week ending March 15, 2025 (week 11). Seasonal influenza activity remains increased across the U.S. but has decreased for five consecutive...

While AI has helped streamline many processes, its ultimate impact may be debatable at this point, and caution in certain areas is warranted, according to some industry experts

Edwards joins as president, markets.

Health care consulting and technology organization awarded 2025 All-Star Awards to nine Prime employees

Designation demonstrates highest level of commitment to quality health care

Designation demonstrates highest level of commitment to quality health care.

Enhanced strategic consultation and new products like Medicare Predictive Model and Enrollment Capabilities are changing Prime’s government programs and delivering better access and costs to members

The content in this publication is not a substitute for professional medical advice. For questions regarding any medical condition or if you need medical advice, please contact your health care...

Prime leaders joined peers from Free Market Health and EmblemHealth at Asembia’s AXS26 conference to share how specialty care needs more visibility, more configurability and practical innovation

A Q&A with Kristen Tveit, SVP, chief financial officer, Magellan Rx

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

AMCP Nexus offers opportunity to nurture next generation of managed care leaders

Live updates from AMCP Annual Meeting

Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...

Configure the table properties Dosage and administration In the Phase 3 VALOR clinical trial, brepocitinib was administered orally once daily at a dose of 15 mg or 30 mg for 52 weeks. Place in...

cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care  Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...

denecimig (Mim8) - Hematologic The Deep dive section features an analysis for select pipeline drugs that are expected to be FDA-approved in the upcoming quarters. Selected agents are expected to...

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of...

Event features Caitlin Berry, senior principal of public policy and government affairs at Prime Therapeutics

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

Recent research presented at AMCP 2026 shows treatment location affects cost and use. Here’s how Prime is poised to support patients.

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Nathan Downhour, senior vice president of strategic pharmacy solutions, led the implementation of Prime’s innovative Advocate+ care model